Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 219 (RN7SKP219) is classified as a pseudogene related to the RN7SK gene, which encodes a component of the 7SK small nuclear ribonucleoprotein (snRNP) complex involved in regulating transcription elongation by RNA polymerase II[1]. As a pseudogene, RN7SKP219 itself does not encode a protein nor produce a functional RNA molecule and is presumed to be non-functional, with no known biological or disease associations, and has not been identified as a therapeutic target[1]. There is insufficient evidence to suggest that RN7SKP219 has any biological function, relevance to disease, or pharmacological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 219 (RN7SKP219).